Még nem toboroz
Medical Nitrous Oxide Combined With Personalized Traumatic Script Exposure for the Treatment of Post-Traumatic Stress Disorder
NCT07927192· 3. fázis· University Hospital, Tours· Forrás
Még nem toboroz
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
2026-526404-71-00· 2. fázis· Agomab Spain S.L.U.· Forrás
Toboroz
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
2024-518365-10-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás
Még nem toboroz
Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer
NCT07759492· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás
Még nem toboroz
A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)
2025-522648-42-01· 2/3. fázis· Crinetics Pharmaceuticals Inc.· Forrás
Még nem toboroz
Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC)
NCT07007325· Korai 1. fázis· Institut Cancerologie de l'Ouest· Forrás
Még nem toboroz
Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease
NCT07420439· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás
Toboroz
Open Label Extension to Assess Long Term Safety and Efficacy of KL1333 in Patients With Primary Mitochondrial Disease
NCT07514338· 2. fázis· Pharming Technologies B.V.· Forrás
Toboroz
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
NCT07351045· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Prospective multicenter randomized controlled double-blind label study of the prophylaxis of recurrent pouchitis after fecal microbiota transplant in UC with ileo-anal anastomosis.
NCT03524352· 3. fázis· Centre Hospitalier Universitaire De Nantes· Forrás
Toboroz
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
NCT07221188· 3. fázis· GlaxoSmithKline· Forrás
Toboroz
Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer
NCT06656598· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás
Toboroz
IFM2024-06 : A multi-center, open-label, phase 2 randomized study of elranatamab plus lenalidomide versus daratumumab plus lenalidomide as post transplantation maintenance therapy in patients with newly-diagnosed myeloma
2024-517325-43-00· 2. fázis· Centre Hospitalier Universitaire De Nantes· Forrás
Fut, nem toboroz
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
NCT06635824· 3. fázis· Genmab· Forrás
Toboroz
MYELOFLUDATEP: Exploratory study evaluating the value of 18F-Fludarabine PET for the initial or relapsed assessment and therapeutic evaluation of patients with symptomatic multiple myeloma.
2024-515219-23-00· 1. fázis· Centre Hospitalier Universitaire De Nantes· Forrás
Fut, nem toboroz
A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD L1 high NSCLC
2023-504753-12-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás
Fut, nem toboroz
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401· 2. fázis· Avalyn Pharma Inc.· Forrás
Fut, nem toboroz
Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure
NCT06045975· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás
Toboroz
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
NCT05718323· 2. fázis· ETOP IBCSG Partners Foundation· Forrás
Fut, nem toboroz
Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease Small-sell Lung Cancer (SCLC)
NCT05856695· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás
Lezárult
Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions
NCT05622071· 2. fázis· UNICANCER· Forrás
Toboroz
Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
NCT05627375· 3. fázis· Centre Hospitalier Universitaire de Saint Etienne· Forrás
Toboroz
Aspirin for the Prevention of Preeclampsia and Pregnancy outcomes in nulliparous women after Assisted Reproductive Technology.
2022-500933-10-00· 4. fázis· Centre Hospitalier Universitaire De Toulouse· Forrás
Fut, nem toboroz
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy
NCT05781308· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás
Fut, nem toboroz
Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD
NCT05612035· 2. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
NCT05650229· 2. fázis· Pharming Technologies B.V.· Forrás
Toboroz
Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
NCT05338190· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás
Fut, nem toboroz
A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
NCT05170204· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study of Rusfertide in Adults With Polycythemia Vera (PV)
NCT05210790· 3. fázis· Protagonist Therapeutics, Inc.· Forrás
Fut, nem toboroz
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
NCT04806451· 3. fázis· Neurocrine Biosciences· Forrás
Fut, nem toboroz
Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)
NCT04621188· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás
Fut, nem toboroz
Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial
NCT04727307· 2. fázis· University Hospital, Montpellier· Forrás
Toboroz
Statins for Venous Event Reduction in Patients With Venous Thromboembolism
NCT04319627· 3. fázis· Ottawa Hospital Research Institute· Forrás
Fut, nem toboroz
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
NCT04490915· 3. fázis· Neurocrine Biosciences· Forrás
Fut, nem toboroz
Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)
NCT01817192· 4. fázis· Razor Genomics· Forrás
Toboroz
Randomised Evaluation of COVID-19 Therapy
NCT04381936· 3. fázis· University of Oxford· Forrás
Toboroz
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás
Toboroz
Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.
NCT03290456· 3. fázis· Hospices Civils de Lyon· Forrás
Fut, nem toboroz
Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients
NCT03799835· 3. fázis· UNICANCER· Forrás
Toboroz
Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole
NCT03656081· 3. fázis· Poitiers University Hospital· Forrás
Fut, nem toboroz
Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients
NCT03643133· 2. fázis· UNICANCER· Forrás
Fut, nem toboroz
Adjuvant immunotherapy after salvage surgery in head and neck squamous cell carcinoma: phase 2 trial evaluating the efficacy and the toxicity of nivolumab alone, and of the combination nivolumab and ipilimumab
2024-516810-39-00· 2. fázis· Institut Gustave Roussy· Forrás